Path Therapeutics, Inc.
Calgary
About Path Therapeutics, Inc.
Path Therapeutics, Inc is involved in the development of a novel neurometabolic, phenotypic drug discovery platform to identify protein targets so that de novo drug discovery can be conducted. Their platform measures improvements in mitochondrial function to identify novel drug targets for brain disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Jun 2020)
- Website: pathbio.com
- Phone: 403.992.3461
Industries & Categories
Biotechnology, Health Care, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/path-therapeutics-inc-3172053 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.